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ABSTRACT
Exfoliative toxin D (ETD) was identified recently
as a new exfoliative toxin serotype. Like other
exfoliative toxins, ETD induces intra-epidermal
cleavage through the granular layer of the epi-
dermis of neonatal mice. The distribution of ETD
production was investigated in Staphylococcus
aureus isolates from infected and colonised
patients in France. The etd gene was found in 55
(10.5%) of 522 isolates tested. Isolates responsible
for bullous impetigo and generalised staphylo-
coccal scalded skin syndrome did not harbour etd,
but etd was significantly more frequent in isolates
causing cutaneous abscesses and furuncles. Most
etd- and Panton–Valentine leukocidin-positive
strains belonged to the clone of community-
acquired methicillin-resistant S. aureus spreading
currently throughout France.
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Staphylococcus aureus produces a variety of extra-
cellular toxins, including enterotoxins, toxic shock
syndrome toxin (TSST1) and exfoliative toxins
(ETs). ETs cause the epidermal cleavage seen in
staphylococcal scalded skin syndrome (SSSS) and
bullous impetigo [1]. Two major serological forms
of ET, designated ETA and ETB, have been linked
to human infections. A third ET (ETC) has been
characterised and purified from a S. aureus isolate
obtained from a horse [2]. ETs SHETA-B and
ExhA-C are responsible for Staphylococcus hyicus
exudative epidermitis in pigs [3]. An ET-like toxin
has also been detected in Staphylococcus interme-
dius (SIET), and may have a pathogenetic role in
canine pyoderma [4].
A new ET, designated ETD, is a 27-kDa protein
with sequence similarities of 40% with ETA, 59%
with ETB, 13% with ETC, 16% with SHET-A, and
63% with SHET-B [5]. Like other ETs, ETD causes
epidermal blisters in newborn mice. The etd gene
is located in tandem with edin-B (epidermal cell
differentiation inhibitor B gene) in a new S. aureus
pathogenicity island, designated the etd patho-
genicity island [5]. The etd gene was detected in
S. aureus isolates from 18 patients with suppura-
tive diseases, but in only one of 88 isolates from
patients with bullous impetigo or generalised
SSSS [5,6]. The aim of the present study was to
investigate the relationship between ETD and
various human S. aureus diseases, including
bullous impetigo and generalised SSSS.
The S. aureus isolates studied were referred to
the French National Reference Centre for Sta-
phylococci (Lyon, France) between 1 January
2003 and 31 December 2003 by hospitals
throughout France. In total, 445 disease isolates
and 77 carriage isolates (nose, eye, pharynx and
vagina) were studied. A single isolate per patient
was included when isolates were considered
identical. Isolates were identified as S. aureus by
their ability to coagulate citrated rabbit plasma
(bioMe´rieux, Marcy-l’Etoile, France) and to pro-
duce clumping factor (Slidex Staph Kit; bio-
Me´rieux).
Genomic DNA was extracted following cul-
ture on agar plates or in brain–heart infusion
broth by a standard phenol–chloroform extrac-
tion procedure. The etd gene was detected by
PCR amplification with sense primer 5¢-AA-
CTATCATGTATCAAGG and antisense primer
5¢-CAGAATTTCCCGACTCAG. The epidermal
cell differentiation inhibitor edin-ABC genes
were detected by PCR with the following
primers mixed in an equimolar ratio: EDINAC-
1, 5¢-GATTTAGATGAGGCAACTAAATGGGG;
EDINAC-2, 5¢-CAGCGTATTCTGTGCCTCTAGG;
EDINB-1, 5¢-GACTTAGTTGAAGCTACTAA-
ATGGGG; and EDINB-2, 5¢-CAGCATATTCTGT-
CCCTCTAGG. Sequences specific for staphylo-
coccal enterotoxin genes (sea-e, seh, sek, sem, sel
and seo), the toxic shock syndrome toxin gene
(tst), the exfoliative toxin A and B genes (eta, etb),
the Panton–Valentine leukocidin (PVL) genes
(lukS-PV–lukF-PV), the LukE–LukD leukotoxin
gene (lukE–lukD), the c-haemolysin gene (hlg),
the c-haemolysin variant gene (hlgv) and acces-
sory gene regulator alleles (agr1–4) were all
detected by PCR as described previously [7,8].
The mecA gene coding for methicillin resistance
was detected by PCR as described by Murakami
et al. [9]. All PCR products were resolved by
electrophoresis through agarose 1.5% w ⁄v gels,
followed by staining with ethidium bromide and
analysis. Pulsed-field gel electrophoresis (PFGE)
was performed as described previously, and
digitised patterns were compared using Taxotron
(Institut Pasteur, Paris, France) software. A PFGE
type corresponded to isolates with PFGE patterns
with > 80% similarity. The v2 test was used to
compare proportions between variable categories,
with all analyses performed with SPSS software
v.11.5 (SPSS Inc. Chicago, IL, USA).
The etd gene was detected in 55 (10.5%) of the
522 S. aureus isolates. It was detected more fre-
quently in the present study than were eta and etb
in previous studies (5.1–6%) [10,11]. Forty-eight
of the 445 disease isolates, and seven of the 77
colonisation isolates, were etd-positive (Table 1).
None of the isolates responsible for bullous
impetigo or generalised SSSS harboured etd,
thereby confirming the original results of Yamag-
uchi et al. [5], who found that only one of 88
isolates from Japanese patients with bullous
impetigo produced ETD.
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SSSS is associated classically with ETA or ETB.
The etd gene was detected mainly in isolates
(n = 41) from patients with skin and soft-tissue
infections, such as furuncles, abscesses and finger
pulp infections (p 0.001), which are caused rarely
by S. aureus strains harbouring eta or etb, but are
associated strongly with production of PVL [7],
and was detected only rarely in isolates from
patients with other suppurative diseases. It is
unclear whether ETD contributes directly to the
pathogenesis of these diseases, but the present
findings support the hypothesis that ETD may
disrupt the cutaneous epithelial barrier and
thereby contribute to bacterial spread [12].
Indeed, purified ETD induces intra-epidermal
cleavage through the granular layer of the epi-
dermis of neonatal mice in a manner similar to
ETA [13] and ETB [14]. As for other ETs, a
possible substrate for ETD is desmoglein 1, a
desmosome trans-membrane glycoprotein belong-
ing to the cadherin gene superfamily [5,14].
The 55 etd-positive isolates were negative for eta
and etb, and belonged to only two PFGE types
(data not shown). Forty-nine isolates belonged to
type I (48 with an etd+, lukS-PV–lukF-PV+, mecA+
genotype, and one with the same genotype except
that it was mecA–). The 48 PVL-positive isolates
belonged to a clone of community-acquired (CA)
methicillin-resistant S. aureus (MRSA) of sequence
type 80 spreading currently throughout Europe
[15,16]. They harboured the agr3 allele, and were
otherwise identical as regards their toxin gene
profiles (negative for tst, hlg and all enterotoxin
genes, and positive for lukE–lukD and hlgv). The
second PFGE type (II) comprised six agr1 isolates
(one lukS-PV–lukF-PV+, mecA–, etd+ isolate and
five lukS-PV–lukF-PV–, mecA–, etd+ isolates)
(Table 2).
All etd-positive isolates were also edin-posit-
ive. EDIN belongs to the ADP-ribosyltransf-
erase-modifying Rho GTPases8. In-vitro, EDIN
induces epidermal hyperplasia [17]. Recent
studies suggest that the skin of patients with
atopic dermatitis and epidermal hyperplasia has
increased binding avidity for S. aureus [18]. It is
therefore conceivable that EDIN facilitates S. au-
reus skin infection, possibly in cooperation with
EDIN-B [5]. The fact that etd and edin have not
been detected in clones of CA-MRSA spreading
in the USA or Oceania suggests that etd and
Table 1. Presence of the etd gene in 522 Staphylococcus
aureus isolates associated with various clinical syndromes
Colonisation ⁄ infection
(no. of isolates tested)
No. (%) of
etd-positive isolates p value
Colonisation (77) 7 (9) NS
Infections (445) 48 (10.5)
Skin infections (188) 41 (74) 0.001
Bullous impetigo (32) 0 (0) NS
Generalised SSSS (14) 0 (0) NS
Cutaneous abscess (54) 18 (33) 0.06
Furuncle (21) 9 (43) NS
Finger pulp infection (8) 4 (50) NS
Secondary skin infection (59) 10 (17) NS
Other infections (257) 7 (13) 0.003
Mastoiditis (8) 2 (25) NS
Pneumonia (43) 1 (2) NS
Sepsis (58) 3 (5) NS
Osteoarthritis (23) 1 (4) NS
Osteomyelitis (11) 0 (0) NS
Endocarditis (19) 0 (0) NS
Other (95) 0 (0) NS
NS, not significant; SSSS, Staphylococcal scalded skin syndrome.
Table 2. Accessory gene profiles of Staphylococcus aureus isolates positive for exfoliative toxin D gene
Genotypes
No. of
isolates agr allele edin
eta,
etb lukE–lukD
Enterotoxin genes
tst hlg hlgv PFGE
sea-e, seh, sek,
sem, sel, seo
etd+,
lukS-PV–lukF-PV+,
mecA+
48 3 + – + – – – + Clone I
etd+,
lukS-PV–lukF-PV–,
mecA–
5 1 + – + s, sel, sem, seo – – + Clone II
1 + – + sem, seo – – + Clone II
1 + – + seb, sem, seo – – + Clone II
1 + – + seb, sem, seo – – + Clone II
1 + – + seb, sem, seo – – + Clone II
etd+,
lukS-PV–lukF-PV+,
mecA–
2 1 + – + seb, sem, seo – – + Clone II
3 + – + – – – + Clone I
agr, accessory gene regulator; edin, epidermal cell differentiation inhibitor genes; eta, etb, exfoliative toxin A and B genes; lukE–lukD, leukotoxin ED genes; sea-e, seh, sek, sel, sem,
seo, genes for enterotoxins SEA–SEA, SEH, SEK, SEL, SEM and SEO, respectively; tst, toxic shock syndrome toxin gene; hlg, c-haemolysin gene; hlgv, c-haemolysin-variant
gene; etd, exfoliative toxin D gene; lukS-PV–lukF-PV, Panton–Valentine leukocidin genes; mecA, methicillin resistance gene; +, present; –, absent; PFGE, pulsed-field
gel electrophoresis.
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edin may be specific genetic traits of European
CA-MRSA.
In conclusion, etd was not associated currently
with bullous impetigo or generalised SSSS, both
of which are caused by ETs. However, etd was
associated with edin and lukS-PV–lukF-PV in CA-
MRSA strains spreading throughout Europe [15],
and this combination may contribute to epide-
micity and virulence.
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ABSTRACT
This study compared the in-vitro ability of
Enterococcus faecium isolates of different origin
to acquire vanA by conjugation in relation to the
occurrence of the esp gene. In total, 29 clinical
isolates (15 ⁄ 29 esp+), 30 normal intestinal micro-
flora isolates (2 ⁄ 30 esp+) and one probiotic strain
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